Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish
March 22, 2018 at 12:18 PM EDT
Mesoblast limited (ADR) (NASDAQ: MESO), a developer of adult stem cell-based products, has struggled to meet key clinical timelines and ...